Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04895618 · ClinicalTrials.gov registry record · NA

The Effect of the Erchonia GVL Low Level Laser Therapy on Neck and Shoulder Pain

A NA study, sponsored by Erchonia Corporation.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT04895618 is a NA study that has completed, run by Erchonia Corporation. The registered enrollment target is 43 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04895618, a NA study, has completed, sponsored by Erchonia Corporation.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

This study is to see if applying green and violet low level laser light to the neck and shoulders can help to reduce pain in the neck and shoulders.

Interventions

  • DEVICE Erchonia GVL

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2020-11-11
Est. Completion 2022-05-20
Phase NA

Sponsor

Erchonia Corporation

34 total trials

What the Registry Record Tells You About NCT04895618

The ClinicalTrials.gov registry entry for NCT04895618 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Erchonia GVL is the first listed.

NCT04895618 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04895618 about?

NCT04895618 is a clinical study titled "The Effect of the Erchonia GVL Low Level Laser Therapy on Neck and Shoulder Pain". This study is to see if applying green and violet low level laser light to the neck and shoulders can help to reduce pain in the neck and shoulders.

What is the current status of trial NCT04895618?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2020-11-11. Estimated completion is 2022-05-20.

What interventions are being tested in trial NCT04895618?

The interventions under investigation include: Erchonia GVL (DEVICE).

Who is sponsoring clinical trial NCT04895618?

This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.